SS-31
⥠Quick Description & Benefits
AKA Elampretide.
Key Benefits:
- â Repair cells
- â Macular degeneration
- â Muscle weakness
- â Energy
- â Cognitive function
- â Improves cardiovascular health
- â Prevents kidney injury
- â Treats lung injury
đŦ Detailed Function & Research
Mechanism & Function
AKA Elampretide. It operates by stimulating specific cellular receptors, activating downstream enzymatic pathways and physiological repair mechanisms without widespread systemic disturbance.
Research & Scientific Support
Extensive pre-clinical and translational models demonstrate consistent receptor affinity and regenerative signalling across controlled studies.
Protocol Notes:
- âĸ AKA Elampretide
- âĸ Good to follow with MOTS-C after SS-31
𧎠Dosing & Reconstitution Calculator
Calculate syringe units or suggest optimal reconstitution solution volume
Volume Guideline: Most subcutaneous injections should fall between 10 and 20 units for optimal comfort, though certain peptides may feel better at volumes up to 60 units. Increments start at 1.0ml in 0.5ml steps.
đ Research Papers & Clinical Studies
Peer-reviewed research and indexed publications for SS-31:
đ Dosing & Administration
âĸ 4 mg daily for 10-20 days âĸ 2 mg on the first day, then 4 mg daily for 12 days (for 50 mg total) Protocols with MOTS-C and Humanin: âĸ 2 months of SS-31, after one month start 2 months MOTS-C, after MOTS-C, one month Humanin. When that ends, resume MOTS-C for 2-3 months then repeat the whole cycle.
đ Pairs Well With
â ī¸ Side Effects
Mild, transient injection site redness or light flushing are most commonly reported.